Vidari Kanda for Reproductive Health

Preliminary evidence 5 studies

Research suggests that Vidari Kanda (Pueraria tuberosa) has a range of traditionally documented reproductive health applications, including use as an aphrodisiac, galactagogue, and fertility tonic, and several laboratory and animal studies provide preliminary biological support for some of these uses. Studies indicate that key isoflavone compounds in the plant, particularly puerarin, genistein, and daidzein, interact with estrogen receptors and may support lactation by increasing prolactin levels and milk yield in rats, while a separate animal study found the plant's fractions may help address estrogen-deficiency-related conditions such as osteoporosis and showed inhibitory effects on certain hormone-sensitive cancer cell lines. The available evidence is drawn primarily from in vitro studies, animal models, and traditional use reviews rather than controlled human clinical trials, and findings are not uniformly positive — at least one study noted potential anti-fertility effects in male rats, introducing a note of caution about reproductive outcomes across sexes. A 2014 review concluded that while the body of preliminary research is promising and consistent with traditional Ayurvedic claims, rigorous human clinical trials are still lacking, meaning the current evidence base cannot yet support definitive conclusions about efficacy or safety in humans.

Related studies

Citations from PubMed and preprint sources. Match score (0-100) reflects automated search ranking, not clinical appraisal.

Title Type Year Direction Match
Pueraria tuberosa: a review on its phytochemical and therapeutic potential. Review 2014 Supports 92
In vivo analysis of puerarin from Pueraria tuberosa as a promising galactagogue. Other 2024 Supports 82
A fraction of Pueraria tuberosa extract, rich in antioxidant compounds, allev... Other 2021 Supports 80
Development of Randomly Amplified Polymorphic DNA Based SCAR Marker for Ident... Other 2011 Supports 65
The aqueous tuber extract of Pueraria tuberosa (Willd.) D.C. caused cytotoxic... Other 2017 Mixed 60

← Back to Vidari Kanda

Medical Disclaimer: Noyemi provides information from published research for educational purposes only. This content is not medical advice and does not replace consultation with a qualified healthcare provider. Always consult your doctor before starting, stopping, or changing any supplement regimen, especially if you take medications or have existing health conditions.